Tag:
avanafil
Latest Headlines
Latest Headlines
Vivus submits NDA for ED drug
Vivus is right on time with its NDA for avanafil, a drug for erectile dysfunction licensed from Japan's Mitsubishi Tanabe Pharma. The drug was tested in 1,350 men, some of whom had diabetes. Data
Vivus readies NDA as Ph3 trial hits goals for ED drug
Mountain View, CA-based Vivus ( $VVUS ) says that its experimental erectile dysfunction drug avanafil hit its goals in a Phase III study. And Vivus, which has been struggling to respond to the FDA's
Vivus ED drug passes its second late-stage test
Shares of Vivus (VVUS) were buoyed this morning by the upbeat assessment of a second round of late-stage data on its erectile dysfunction drug avanafil. Two doses of the drug spurred statistically
